A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts ...

A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

In phase 2 of the FORWARD study, 83% of participants with type 1 diabetes achieved insulin independence a year after receiving zimislecel (formerly VX-880), an islet cell therapy developed ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...